Drug Information

Drug General Information
Drug ID
D0J3SW
Former ID
DNC000286
Drug Name
BCEAB
Drug Type
Small molecular drug
Indication Discovery agent Investigative [535651]
Structure
Download
2D MOL

3D MOL
Formula
C20H38N6O4
Canonical SMILES
CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C=O)NC(=O)C
InChI
1S/C20H38N6O4/c1-12(2)9-16(24-14(5)28)19(30)26-17(10-13(3)4)18(29)25-15(11-27)7-6-8-23-20(21)22/h11-13,15-17H,6-10H2,1-5H3,(H,24,28)(H,25,29)(H,26,30)(H4,21,22,23)/t15-,16-,17-/m0/s1
InChIKey
GDBQQVLCIARPGH-ULQDDVLXSA-N
CAS Number
CAS 24365-47-7
PubChem Compound ID
72429
PubChem Substance ID
602112, 7979525, 11121773, 11122253, 11362949, 11365511, 11368073, 11371069, 11371070, 11373674, 11376235, 16003641, 26756847, 43128595, 47944494, 48170149, 48413940, 49857450, 50061803, 50078012, 50111452, 53788333, 56231459, 57318714, 77099929, 92310124, 99301036, 99302556, 104060153, 104352924, 117585558, 127936552, 134339750, 134339752, 134339755, 134339756, 134340176, 135030613, 139421944, 160661376, 175267735, 184589588, 223653355, 226888611, 241182192, 241375264, 242084562, 249617260, 250132850, 252344670
Target and Pathway
Target(s) Chymase Target Info Inhibitor [535651]
KEGG Pathway Renin-angiotensin system
Reactome Activation of Matrix Metalloproteinases
Metabolism of Angiotensinogen to Angiotensins
WikiPathways ACE Inhibitor Pathway
Metabolism of Angiotensinogen to Angiotensins
References
Ref 535651Development of a chymase inhibitor: pharmacological characterization of a chymase inhibitor in inflamed tissue remodeling and fibrosis. Jpn J Pharmacol. 2002 Nov;90(3):206-9.
Ref 535651Development of a chymase inhibitor: pharmacological characterization of a chymase inhibitor in inflamed tissue remodeling and fibrosis. Jpn J Pharmacol. 2002 Nov;90(3):206-9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.